» Articles » PMID: 38698045

COPII Cage Assembly Factor Sec13 Integrates Information Flow Regulating Endomembrane Function in Response to Human Variation

Overview
Journal Sci Rep
Specialty Science
Date 2024 May 2
PMID 38698045
Authors
Affiliations
Soon will be listed here.
Abstract

How information flow is coordinated for managing transit of 1/3 of the genome through endomembrane pathways by the coat complex II (COPII) system in response to human variation remains an enigma. By examining the interactome of the COPII cage-assembly component Sec13, we show that it is simultaneously associated with multiple protein complexes that facilitate different features of a continuous program of chromatin organization, transcription, translation, trafficking, and degradation steps that are differentially sensitive to Sec13 levels. For the trafficking step, and unlike other COPII components, reduction of Sec13 expression decreased the ubiquitination and degradation of wild-type (WT) and F508del variant cargo protein cystic fibrosis transmembrane conductance regulator (CFTR) leading to a striking increase in fold stability suggesting that the events differentiating export from degradation are critically dependent on COPII cage assembly at the ER Golgi intermediate compartment (ERGIC) associated recycling and degradation step linked to COPI exchange. Given Sec13's multiple roles in protein complex assemblies that change in response to its expression, we suggest that Sec13 serves as an unanticipated master regulator coordinating information flow from the genome to the proteome to facilitate spatial covariant features initiating and maintaining design and function of membrane architecture in response to human variation.

References
1.
Lu C, Kim J . Consequences of mutations in the genes of the ER export machinery COPII in vertebrates. Cell Stress Chaperones. 2020; 25(2):199-209. PMC: 7058761. DOI: 10.1007/s12192-019-01062-3. View

2.
Hillenaar T, Beekman J, van der Sluijs P, Braakman I . Redefining Hypo- and Hyper-Responding Phenotypes of CFTR Mutants for Understanding and Therapy. Int J Mol Sci. 2022; 23(23). PMC: 9735543. DOI: 10.3390/ijms232315170. View

3.
Cui Y, Parashar S, Ferro-Novick S . A new role for a COPII cargo adaptor in autophagy. Autophagy. 2019; 16(2):376-378. PMC: 6984482. DOI: 10.1080/15548627.2019.1699347. View

4.
Amaral M, Balch W . Hallmarks of therapeutic management of the cystic fibrosis functional landscape. J Cyst Fibros. 2015; 14(6):687-99. PMC: 4644672. DOI: 10.1016/j.jcf.2015.09.006. View

5.
Phuyal S, Farhan H . Want to leave the ER? We offer vesicles, tubules, and tunnels. J Cell Biol. 2021; 220(6). PMC: 8129806. DOI: 10.1083/jcb.202104062. View